2015 CUOG-CUA-ASTELLAS AWARDS: ($50,000 RECIPIENTS):

“Evaluation of different test platforms for analysis of androgen receptor splice variants in the peripheral blood of patients with castration resistant prostate cancer”

  • Tilman Todenhöfer
  • Vancouver Prostate Centre/UBC
  • $50,000

“Multi-target injectable paste as a novel treatment for localized prostate cancer – Preclinical modeling and optimization”

  • Samir Bidnur
  • Vancouver Prostate Centre/UBC
  • $50,000

2015 CUOG-CUA-ASTELLAS AWARDS: ($25,000 RECIPIENTS):

“Delineation of the biomarker value of aldehyde dehydrogenase 3A1 (ALDH3A1) in prostate cancer progression”

  • Anil Kapoor
  • McMaster University
  • $25,000

“Effect of Omega-3 Polyunsaturated Fatty Acid Dietary Supplementation on Prostate Cancer in Relation to the Fatty Acid Content of Diet”

  • Nikunj Gevariya
  • CHU de Québec Research Centre/Laval University
  • $25,000

2015 CUOG INDUSTRY SPONSORED RESEARCH AWARDS:

“Validation of an IF approach to support the selection of biomarkers for PCa Progression. “

  • Investigator/Supervisor: Clairefond/Saad
  • Sponsor: CUOG
  • $10,000

“Androgen receptor mutations in circulating cell-free DNA as markers of progression or response to novel androgen axis inhibitors. “

    • Investigator/Supervisor: Wyatt/Chi
    • Sponsor: Janssen
    • $25,000

“The role of telomere maintenance in testicular cancer relapse. “

    • Investigator/Supervisor: Leao/Hamilton
    • Sponsor: Bayer
    • $15,000

 

” Identification of genetic determinants of clonal resistance to radiotherapy in prostate cancer.”

    • Investigator/Supervisor: Chua/Bristow
    • Sponsor: Sanofi
    • $15,000

 

“Therapeutics targeting semaphoring 3C in castration resistant prostate cancer CRPC)”

    • Investigator/Supervisor: Imada/Gleave
    • Sponsor: BNIT
    • $10,000

 

“Preclinical assessment of IKKb and Bcl2 inhibitors to overcome Enzalutamide resistance. “

    • Investigator/Supervisor: Jeganathan/Joshua
    • Sponsor: Allergan (formerly Actavis)
    • $10,000

 

“Interogating HMGB1 in bladder cancer treated with trimodal therapy”

    • Investigator/Supervisor: Mohtashami/Kassouf
    • Sponsor: CUOG
    • $10,000

 

“Development of a 3D in vitro human bladder cancer model to study anti-cancer therapies. “

    • Investigator/Supervisor: Goulet/Pouliot
    • Sponsor: Bladder Cancer Canada
    • $20,000

 

“A Window of Opportunity Study to Evaluate the Role of the Combination of Metformin and Simvastatin as a Neoadjuvant Therapy in Invasive Bladder Cancer”

    • Investigator/Supervisor: McPherson/Izawa
    • Sponsor: Bladder Cancer Canada
    • $10,000

 

“Non-muscle invasive orthotopic xenotranplant bladder cancer animal model. “

    • Investigator/Supervisor: Chavez-Munoz/So
    • Sponsor: Bladder Cancer Canada
    • $10,000

 

A novel role of PTEN in interferon mediated tumor inflammatory responses in prostate cancer.

  • Investigator/Supervisor: Koti/Siemens
  • Sponsor: Amgen
  • $10,000